These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 22432964)

  • 21. The modified BODE index: validation with mortality in COPD.
    Cote CG; Pinto-Plata VM; Marin JM; Nekach H; Dordelly LJ; Celli BR
    Eur Respir J; 2008 Nov; 32(5):1269-74. PubMed ID: 18579541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.
    Van Tho N; Ogawa E; Trang le TH; Ryujin Y; Kanda R; Nakagawa H; Goto K; Fukunaga K; Higami Y; Seto R; Wada H; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Ann Am Thorac Soc; 2015 Jul; 12(7):988-96. PubMed ID: 25844673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
    Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
    Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.
    Martinez CH; Chen YH; Westgate PM; Liu LX; Murray S; Curtis JL; Make BJ; Kazerooni EA; Lynch DA; Marchetti N; Washko GR; Martinez FJ; Han MK;
    Thorax; 2012 May; 67(5):399-406. PubMed ID: 22514236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The BODE index after lung volume reduction surgery correlates with survival.
    Imfeld S; Bloch KE; Weder W; Russi EW
    Chest; 2006 Apr; 129(4):873-8. PubMed ID: 16608932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD.
    Díaz AA; Morales A; Díaz JC; Ramos C; Klaassen J; Saldías F; Aravena C; Díaz R; Lisboa C; Washko GR; Díaz O
    Respir Med; 2013 Apr; 107(4):570-9. PubMed ID: 23313036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year.
    Lederer DJ; Thomashow BM; Ginsburg ME; Austin JH; Bartels MN; Yip CK; Jellen PA; Brogan FL; Kawut SM; Maxfield RA; DiMango AM; Simonelli PF; Gorenstein LA; Pearson GD; Sonett JR
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1434-8. PubMed ID: 17532935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between daily living activities (ADL) limitation and the BODE index in patients with chronic obstructive pulmonary disease.
    Simon KM; Carpes MF; Corrêa KS; dos Santos K; Karloh M; Mayer AF
    Rev Bras Fisioter; 2011; 15(3):212-8. PubMed ID: 21829985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.
    Andrianopoulos V; Celli BR; Franssen FM; Pinto-Plata VM; Calverley PM; Vanfleteren LE; Vogiatzis I; Vestbo J; Agusti A; Bakke PS; Rennard SI; MacNee W; Tal-Singer R; Yates JC; Wouters EF; Spruit MA
    Respir Med; 2016 Oct; 119():87-95. PubMed ID: 27692154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway count and emphysema assessed by chest CT imaging predicts clinical outcome in smokers.
    Diaz AA; Valim C; Yamashiro T; Estépar RS; Ross JC; Matsuoka S; Bartholmai B; Hatabu H; Silverman EK; Washko GR
    Chest; 2010 Oct; 138(4):880-7. PubMed ID: 20558554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation.
    Moberg M; Vestbo J; Martinez G; Williams JE; Ladelund S; Lange P; Ringbaek T
    COPD; 2014 Aug; 11(4):381-7. PubMed ID: 24111845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicomponent indices to predict survival in COPD: the COCOMICS study.
    Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de Torres JP; Martínez-Camblor P; Miravitlles M; Celli BR; Soriano JB
    Eur Respir J; 2013 Aug; 42(2):323-32. PubMed ID: 23222874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation.
    Orlandi I; Moroni C; Camiciottoli G; Bartolucci M; Pistolesi M; Villari N; Mascalchi M
    Radiology; 2005 Feb; 234(2):604-10. PubMed ID: 15671010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study.
    Cui L; Ji X; Xie M; Dou S; Wang W; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2823-2830. PubMed ID: 29033563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
    Karayama M; Inui N; Yasui H; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1333-1342. PubMed ID: 31296985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.